The ProSense® Cryoablation System could be a game changer for women over 70 with early-stage, low-risk breast cancer. For decades, breast cancer treatment has often meant surgery, which can be an ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest announcement is out from ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. A molecular-level understanding of crystal growth modification is essential for ...
A UN expert on Tuesday welcomed the decision by consensus during the 48th session of the UN Human Rights Council to establish an independent investigative mechanism for Afghanistan. The decision also ...
Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi were awarded the 2025 Nobel Prize in Physiology or Medicine on Monday for their collective work in the discovery of specialized immune cells that roam ...
Forbes contributors publish independent expert analyses and insights. Dr Ewelina U Ochab is a Forbes contributor, lawyer, and author. A general view shows the Human Rights and Alliance of ...
IceCure Medical’s tumor-freezing treatment ProSense has nabbed FDA approval, making it the first medical device of its kind to be endorsed for the local treatment of breast cancer. The Israeli medical ...
Icecure Medical Ltd. reported that the U.S. FDA has granted marketing authorization to Icecure's de novo application for the Prosense cryoablation system for the local treatment of breast cancer in ...
IceCure Medical (Nasdaq:ICCM) announced today that the FDA granted marketing authorization for its ProSense cryoablation system for breast cancer. The company picked up de novo approval for the local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback